Optimizing medical treatment of abdominal ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Optimizing medical treatment of abdominal aortic aneurysm: interest of vascular centers
Auteur(s) :
Madika, Anne-Laure [Auteur]
Institut Coeur Poumon [CHU Lille]
Mounier-Vehier, Claire [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Azzaoui, Richard Oussama [Auteur]
Institut Coeur Poumon [CHU Lille]
Institut Coeur Poumon [CHU Lille]
Mounier-Vehier, Claire [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Azzaoui, Richard Oussama [Auteur]
Institut Coeur Poumon [CHU Lille]
Titre de la revue :
La Presse medicale
Nom court de la revue :
Presse Med
Numéro :
47
Pagination :
161-166
Éditeur :
Elsevier
Date de publication :
2018-02-27
ISSN :
2213-0276
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Diagnosis of abdominal aortic aneurysm (AAA) at preoperative stage is increasingly frequent. It carries both a local risk of rupture and an increased global cardiovascular risk. Patients with AAA have indeed a 20 times ...
Lire la suite >Diagnosis of abdominal aortic aneurysm (AAA) at preoperative stage is increasingly frequent. It carries both a local risk of rupture and an increased global cardiovascular risk. Patients with AAA have indeed a 20 times higher risk of dying from myocardial infarction or stroke than from a ruptured aneurysm. Cardiovascular risk factors control is therefore essential, particularly smoking cessation. Treatment in cardiovascular prevention is also warranted. Seeking for atheromatous sites is needed as they determine prognosis. Evidence of the benefit of medical treatment to slow AAA growth is still lacking. In practice, it is recommended to prescribe statins and angiotensin converting enzyme inhibitor to prevent cardiovascular events. These preventive measures are as well necessary to improve postoperative prognosis and must be continued after surgical repair. A vascular medical and surgical cooperation is primordial to enhance comprehensive management of patients with AAA.Lire moins >
Lire la suite >Diagnosis of abdominal aortic aneurysm (AAA) at preoperative stage is increasingly frequent. It carries both a local risk of rupture and an increased global cardiovascular risk. Patients with AAA have indeed a 20 times higher risk of dying from myocardial infarction or stroke than from a ruptured aneurysm. Cardiovascular risk factors control is therefore essential, particularly smoking cessation. Treatment in cardiovascular prevention is also warranted. Seeking for atheromatous sites is needed as they determine prognosis. Evidence of the benefit of medical treatment to slow AAA growth is still lacking. In practice, it is recommended to prescribe statins and angiotensin converting enzyme inhibitor to prevent cardiovascular events. These preventive measures are as well necessary to improve postoperative prognosis and must be continued after surgical repair. A vascular medical and surgical cooperation is primordial to enhance comprehensive management of patients with AAA.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Université de Lille
Université de Lille
Date de dépôt :
2019-12-09T16:55:50Z
2024-03-06T08:53:08Z
2024-03-06T08:53:08Z